Sun Pharmaceutical Industries Ltd.
-31.35 (-1.84%) Sun Pharmaceutical Industries reports 40% rise in Q1 consolidated net profit
Date: 01-08-2024Sun Pharmaceutical Industries has reported results for first quarter ended June 30, 2024 (Q1FY25).
The company has reported 37.52% fall in net profit at Rs 237.82 crore for Q1FY25 as compared to Rs 380.64 crore for the same quarter in the previous year. Total income of the company decreased by 1.05% at Rs 4,580.81 crore for Q1FY25 as compared to Rs 4,629.61 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 40.20% rise in its net profit at Rs 2,835.62 crore for the quarter ended June 30, 2024 as compared to Rs 2,022.54 crore for the same quarter in the previous year. Total income of the company increased by 8.56% at Rs 13,185.30 crore for Q1FY25 as compared to Rs 12,145.28 crore for the corresponding quarter previous year.